Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant vs Sequential Arimidex with Radiotherapy in Breast Cancer
NCT01402193Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Jul 2011
- Primary completion
- Dec 2014
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of anastrozole in breast cancer, sponsored by Fudan University. Status: unknown.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01402193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402193.